In addition to GSS, three genes encompassed in the “glutathione metabolism” pathway had higher expression (GGTLA1, GPX2, and GPX3), and two genes had lower expression (OPLAH and ANPEP) in NASH, suggesting an increase in glutathione utilisation. This evidence concerns the gene GPX3 and metabolic dysfunction-associated steatohepatitis.